NIH-led study to assess community-based hepatitis C treatment in Washington, D.C.

(NIH/National Institute of Allergy and Infectious Diseases) Officials from NIH and the city of Washington, D.C., launched a clinical trial to examine whether primary care physicians and other health care providers, such as nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians to treat people with hepatitis C virus (HCV) infection. The trial, which will involve 600 adult D.C. residents infected with HCV alone or co-infected with HCV and HIV, also will examine the long-term effects of the treatment.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news